- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01918670
A French Multi-centric Atrial Fibrillation Catheter Ablation Survey (FrenchAF)
Atrial fibrillation is the most frequent sustained arrhythmia. Catheter ablation is a procedure that is currently used for the treatment of symptomatic atrial fibrillation patients.
We have organized a multi-centric national survey of catheter ablation of atrial fibrillation in order to have a feedback on the type of procedures being performed and the overall results (freedom of atrial fibrillation) over an average follow-up of 18 months.
Study Overview
Status
Intervention / Treatment
Study Type
Contacts and Locations
Study Locations
-
-
-
Toulouse, France
- Clinique Pasteur
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- all patients undergoing catheter ablation of atrial fibrillation or left atrial flutter
Exclusion Criteria:
- patients undergoing catheter ablation of other types of arrhythmia
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Pasteur
|
electric pulmonary vein disconnection
|
|
Grenoble
|
electric pulmonary vein disconnection
|
|
Nantes
|
electric pulmonary vein disconnection
|
|
Parly
|
electric pulmonary vein disconnection
|
|
Rennes
|
electric pulmonary vein disconnection
|
|
Rouen
|
electric pulmonary vein disconnection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Atrial fibrillation relapse
Time Frame: starting 3 months after the procedure till an average of 18months follow-up
|
Documentation of atrial fibrillation relapse (symptomatic or asymptomatic) after the first 3 months after the index procedure
|
starting 3 months after the procedure till an average of 18months follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Early atrial fibrillation relapse
Time Frame: first 3 months
|
Documented atrial fibrillation relapse (symptomatic or asymptomatic) in the first 3 months after the index procedure
|
first 3 months
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FrenchAFAblationSurvey
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Observation of Outcome After Catheter Ablation of Atrial Fibrillation
-
University Hospital, Basel, SwitzerlandRecruitingCatheter-based Ablation of Atrial FibrillationSwitzerland
-
China National Center for Cardiovascular DiseasesRecruitingAtrial Fibrillation Ablation | Atrial Fibrillation (AF) | Radiofrequency Catheter Ablation | Atrial Fibrillation Recurrent | Pulsed Field AblationChina
-
Wroclaw Medical UniversityRecruitingAtrial Fibrillation (AF) | Radiofrequency Catheter Ablation | Ablation Techniques | Pulsed Field AblationPoland
-
Deeptankar DeMazumderRelaxera Pharmaceuticals; McGowan Institute for Regenerative Medicine, University... and other collaboratorsNot yet recruitingHeart Failure | Stroke | Arrhythmia | Oxidative Stress | Atrial Fibrillation (AF) | Catheter Ablation | Ablation of Atrial Fibrillation | Major Cardiovascular Event
-
Yonsei UniversityRecruitingAtrial Fibrillation Patients With Moderate or High Stroke Risk Who Had Undergone Catheter Ablation of Atrial FibrillationKorea, Republic of
-
Ana Rita Londral, PhDNot yet recruitingAtrial Fibrillation (AF) | Catheter Ablation
-
Beijing Anzhen HospitalNot yet recruitingPersistent Atrial Fibrillation | Radiofrequency Catheter Ablation | Pulsed Field AblationChina
-
The Third People's Hospital of ChengduNot yet recruitingUltra-High Power Ablation,Safety of Atrial Fibrillation Ablation
-
Semmelweis University Heart and Vascular CenterUnknownPersistent Atrial Fibrillation | Catheter AblationHungary
-
Medical College of WisconsinActive, not recruitingHeart Failure | Atrial Fibrillation (AF) | Catheter Ablation | Guideline ImplementationUnited States
Clinical Trials on catheter ablation of atrial fibrillation
-
Shanghai Chest HospitalHefei Binhu Hospital; The Second People's Hospital of Anhui Province; The Third... and other collaboratorsNot yet recruitingAtrial Fibrillation (AF) | HFpEF - Heart Failure with Preserved Ejection FractionChina
-
Heart Rhythm Clinical and Research Solutions, LLCAbbottTerminatedAtrial FibrillationUnited States
-
Yonsei UniversityUnknownAtrial FibrillationKorea, Republic of
-
Antonio Berruezo, MD, PhDRecruiting
-
University of Turin, ItalyUniversity of Padova; Centro Cardiologico Monzino; Policlinico Casilino ASL RMB; Humanitas Research Hospital IRCCS, Rozzano-MilanUnknownPersistent Atrial Fibrillation | Congestive Heart Failure Due to Left Ventricular Systolic Dysfunction
-
Farapulse, Inc.CompletedParoxysmal Atrial FibrillationCroatia
-
Stanford UniversityTerminatedAtrial Fibrillation | Morbid ObesityUnited States
-
Abbott Medical DevicesCompletedParoxysmal Atrial FibrillationUnited States
-
University Hospital, Basel, SwitzerlandRecruitingCatheter-based Ablation of Atrial FibrillationSwitzerland
-
University of LeicesterCompleted